Tarsus Pharmaceuticals TARS
NASDAQ TARS
$78.61 +1.92 (+2.50%)
At close: Sep 30, 2026 · 4:00 PM EDT

Tarsus Pharmaceuticals (TARS) Capital Expenditures (2019 - 2026)

Updated

Tarsus Pharmaceuticals' Capital Expenditures was $4.07 million in Q2 2026, up 306.5% from $1 million a year earlier but down 30.1% from the prior quarter.

Analysis

Tarsus Pharmaceuticals (TARS) Capital Expenditures (2019 - 2026) Analysis & Trends

On a trailing twelve-month basis, Tarsus Pharmaceuticals' Capital Expenditures was $18.16 million through Jun 30, 2026, up 833.4% year-over-year; for FY2025, it was $9.86 million, up 529.2% from FY2024.

  • Capital Expenditures has now increased for three consecutive years, with a five-year compound annual growth rate of 84.9% (FY2020 to FY2025).
  • In earlier years, Capital Expenditures was $1.57 million in FY2024 (+4.3%), $1.5 million in FY2023 (+196.8%), $506,000 in FY2022 (-13.7%) and $586,000 in FY2021 (+28.5%).
  • Quarterly Capital Expenditures has moved between $72,000 (Q4 2024) and $6.36 million (Q4 2025) over five years.
  • Compared with a year earlier, Capital Expenditures was higher in four of the last six quarters, with growth averaging 330.1%.
  • The best year-over-year quarter for Capital Expenditures over five years was Q1 2026 (growth of 886.1%); the worst was Q4 2022 (a decline of 53.6%).
  • Per Business Quant data, TARS's Capital Expenditures in the three quarters before Q2 2026 was $5.82 million (Q1 2026), $6.36 million (Q4 2025) and $1.91 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 1.32 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 322.00 Mn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 893.00 Mn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -321.00 Mn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -763.00 Mn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 513.00 Mn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 140.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 533.00 Mn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 112.20 Mn
10 Tarsus Pharmaceuticals 3.32 Bn 2.26 Bn 161.80 Mn 4.07 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.07 Mn
Mar 31, 2026 5.82 Mn
Dec 31, 2025 6.36 Mn
Sep 30, 2025 1.91 Mn
Jun 30, 2025 1.00 Mn
Mar 31, 2025 590,000.00
Dec 31, 2024 72,000.00
Sep 30, 2024 282,000.00
Jun 30, 2024 1.04 Mn
Mar 31, 2024 174,000.00
Sep 30, 2023 375,000.00
Jun 30, 2023 787,000.00
Mar 31, 2023 340,000.00
Dec 31, 2022 127,000.00
Sep 30, 2022 96,000.00
Jun 30, 2022 122,000.00
Mar 31, 2022 161,000.00
Dec 31, 2021 274,000.00
Sep 30, 2021 121,000.00
Jun 30, 2021 16,000.00
API Access

Tarsus Pharmaceuticals Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=TARS&period=max&api_key=YOUR_API_KEY